Tonix Pharmaceuticals Announces Proposed Public Offering

This offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No. 333- 266982) previously filed with the U.S. Securities and Exchange Commission (the "SEC"). The offering will be made only by means of a prospectus supplement and accompanying prospectus. The preliminary prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov. Electro ...